logo
#

Latest news with #Soi

Max Healthcare Institute Q4 PAT up 21 pc at Rs 376 cr
Max Healthcare Institute Q4 PAT up 21 pc at Rs 376 cr

Time of India

time21-05-2025

  • Business
  • Time of India

Max Healthcare Institute Q4 PAT up 21 pc at Rs 376 cr

NEW DELHI: Max Healthcare Institute Ltd on Tuesday reported a 21 per cent rise in profit after tax at Rs 376 crore in the fourth quarter ended March 31, 2025 on the back of rise in revenues. The company had posted a profit after tax of Rs 311 crore in the fourth quarter of the previous fiscal, Max Healthcare Institute Ltd said in a statement. The network gross revenue was at Rs 2,429 crore reflecting a growth of 29 per cent, as compared to Rs 1,888 crore in the corresponding quarter of the previous fiscal, it added. Bed occupancy for the quarter was at 75 per cent, with occupied bed days (OBDs) up by 30 per cent year-on-year and the average revenue per occupied bed was at Rs 77,100 in Q4 FY25, as compared to Rs 76,800 in Q4 FY24, the company said. Max Healthcare Institute Ltd Chairman and Managing Director, Abhay Soi said during the quarter, the company took significant strategic steps to position itself for long-term growth, including corporate actions and two M&A transactions. "Notably, we completed the acquisition of land adjoining Max Super Specialty Hospital, Vaishali, paving the way for a brownfield expansion in this very busy hospital," he added. Soi further said,"As we look ahead, we are excited about commencing the operations at our three new brownfield towers in Saket, Nanavati and Mohali hospitals in the next three months and adding 1,500 beds to the capacity in the current financial year, which will further reinforce our leadership in quality healthcare delivery across geographies that we operate in." In a regulatory filing, the company said its board has recommended a final dividend of Rs 1.5 per equity share of face value of Rs 10 for the financial year 2024-25, subject to approval of shareholders in the forthcoming annual general meeting. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

Max Hits ₹9,000 Cr in FY25, Q4 revenue soars 29% on higher bed occupancy
Max Hits ₹9,000 Cr in FY25, Q4 revenue soars 29% on higher bed occupancy

Time of India

time20-05-2025

  • Business
  • Time of India

Max Hits ₹9,000 Cr in FY25, Q4 revenue soars 29% on higher bed occupancy

Mumbai: Corporate Hospital chain, Max Healthcare Institute Q4 FY2024-25 revenue reported a growth of 29 per cent to ₹2,429 crore, up against ₹1,888 crore from the year ago quarter. For the January-March quarter the hospital's net profit went up 21 per cent to ₹376 crore, against the previous year figures of ₹311 crore while the earnings before interest and taxes (EBITDA) stood at ₹632 crore. The hospitals bed occupancy for the quarter was at 75 per cent, with a 30 per cent increase in bed occupied days (BOD) ad the ARPOB (Average Revenue Per Occupied Bed) stood at ₹77.1 thousand, up against ₹76.8 thousand reported in the year ago period. Overall EBITDA per bed was ₹ 73.9 lakhs compared to ₹76 lakhs in Q4 FY24 and the share of revenue from new units stood at 15 per cent compared to 2 per cent in the year ago period. During the period Max entered into a Long-term Service Agreement to sett up a 200-bed hospital in Pitampura, Delhi in association with Bharat Prakritik Chikitsa Mission. 'We have reported the 18th consecutive quarter of year-on-year growth in both Revenue and Operating EBITDA — a testament to the strength of our operating model, in Q4 we took significant strategic steps for long-term growth, including corporate actions and two M&A transactions,' said Abhay Soi, Chairman and Managing Director, Max Healthcare Institute Ltd. For the full financial year Max gross revenue went up 26 per cent YoY to ₹9,065 crore, while the net profit went up 9 per cent to ₹1,392 crore , attributed with the 'increase in OBDs.' Outlining the company's future plans, Soi said, 'We are commencing operations at our three new brownfield towers in Saket, Nanavati, and Mohali in the next three months and will add 1,500 beds to our capacity in the current financial year.' Recently while inaugurating its Dwarka-based 300-bed super speciality facility, Soi had voiced that, the company will invest '₹6,000 crore by 2028 to add 3,700 beds across key locations in India." Currently the hospital chain operates a network of 22 hospitals with a total strenth of around 5000 beds and caters to more than 30 specialities.

Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%
Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%

Business Standard

time20-05-2025

  • Business
  • Business Standard

Max Healthcare Q4 net profit rises 26.8% to Rs 319 crore, revenue up 32%

Max Healthcare Institute on Tuesday reported a 26.8 per cent year-on-year (Y-o-Y) rise in consolidated net profit in the March quarter of financial year 2024–25 (Q4 FY25) to Rs 319 crore, up from Rs 251.54 crore reported in the same quarter last year. The New Delhi-based hospital chain's revenue from operations rose to Rs 1,909.74 crore, a 32 per cent Y-o-Y rise from Rs 1,422.90 crore in Q4 FY24. Sequentially, the company's net profit rose by 33.8 per cent, while revenue grew marginally by 2 per cent from Rs 238.80 crore and Rs 1,868.31 crore recorded in Q3 FY25, respectively. The company has earlier stated that three of its partner healthcare facilities in New Delhi — Max Balaji Hospital, Max Smart Super Speciality Hospital and Max Saket Super Speciality Hospital — are not included in consolidated financial statements. If the three facilities are considered, revenue for the whole entity stands at Rs 2,302 crore, and net profit would be Rs 376 crore, according to the company's investor presentation. The on-year rise in revenue was attributed to a rise in occupied bed capacity at new facilities and a subsequent increase in the average revenue per occupied bed (Arpob) per day. In the March quarter, Max Healthcare saw its operational bed capacity go up by 188 beds, mainly at Lucknow, Dwarka and BLK Max Hospitals. 'Overall occupancy stood at 75 per cent, with occupied bed days (OBDs) growing by 30 per cent on-year,' the company said. The company's Arpob per OBD also stood at Rs 77,100, up from Rs 76,800 in Q4 FY24. It also saw a 28 per cent year-on-year increase in international patient revenue to Rs 202 crore in Q4 FY25, comprising nearly 9 per cent of the hospital's revenue. Abhay Soi, chairman and managing director, Max Healthcare, said that the company took strategic steps in Q4 to position it for long-term growth, including corporate actions and two M&A transactions. This includes execution of a long-term service agreement to establish a 200-bed hospital in north-west Delhi and a sale deed for the purchase of a one-acre land parcel, along with the Max Super Speciality Hospital in Uttar Pradesh's Vaishali building. 'The property is adjoining the existing hospital premises and will enable brownfield expansion of the hospital's capacity from 387 beds to 527 beds, within the next 30 months,' Max stated in a regulatory filing. Soi added that the company will also be commencing operations at three new brownfield towers in Saket, Nanavati and Mohali hospitals in the next three months. On the company's expansion plans, Soi had previously told Business Standard that Max is looking to expand bed capacity by at least 1,500, or 30 per cent of its current size, reaching around 6,500 beds, in the ongoing financial year 2025–26 (FY26).

Max Healthcare Q4 results: Profit rises 27% at ₹319 cr, dividend declared
Max Healthcare Q4 results: Profit rises 27% at ₹319 cr, dividend declared

Business Standard

time20-05-2025

  • Business
  • Business Standard

Max Healthcare Q4 results: Profit rises 27% at ₹319 cr, dividend declared

Max Healthcare on Tuesday announced a consolidated net profit of ₹319 crore for the quarter ended March 31, 2025 (Q4 FY25), marking a 26.8 per cent increase compared to ₹251.54 crore reported in the same quarter last year (Q4 FY24). Sequentially, the profit rose 33.6 per cent from ₹238.8 crore recorded in Q3 FY25. The company's consolidated revenue from operations stood at ₹1,956.86 crore in Q4 FY25, up 33.4 per cent from ₹1,467.02 crore in Q4 FY24. On a sequential basis, revenue rose 2.9 per cent from ₹1,901.51 crore in Q3 FY25. 'We are proud to report the 18th consecutive quarter of year-on-year growth in both Revenue and Operating EBITDA — a testament to the strength of our operating model, the trust of our patients, and the relentless efforts of our teams,' said Abhay Soi, chairman and MD, Max Healthcare Institute Ltd. 'We also took significant strategic steps in Q4 to position the company for long-term growth, including corporate actions and two M&A transactions. Notably, we completed the acquisition of land adjoining MSSH, Vaishali, paving the way for a brownfield expansion in this very busy hospital. As we look ahead, we are excited about commencing the operations at our three new brownfield towers in Saket, Nanavati and Mohali hospitals in the next three months and adding 1,500 beds to the capacity in the current financial year, which will further reinforce our leadership in quality healthcare delivery across geographies that we operate in,' Soi said. Max Healthcare FY25 results For the entire year, Max Healthcare reported a consolidated net profit of ₹1,075.88 crore, marking a modest increase from ₹1,057.64 crore in FY24. Meanwhile, the company's revenue from operations for FY25 rose significantly to ₹7,028.46 crore, up 30 per cent from ₹5,406.02 crore in the previous fiscal year. Dividend announced Meanwhile, the board of directors of the company recommended a dividend of ₹1.5 per share for the financial year 2024-25, subject to the approval of shareholders. Shares of Max Healthcare were last traded at ₹1165.30 apiece on the BSE at the closing of the market. Max Healthcare Q4 highlights Profit: ₹319 crore Revenue: ₹1,956.86 crore EPS: ₹3.28 (basic), ₹3.26 (diluted) Max Healthcare FY highlights: Profit: ₹1,075.88 crore Revenue: ₹7,028.46 crore EPS: ₹11.07 (basic), ₹11.01 (diluted)

"Unlocking Growth Requires Smoother Approvals and a Favorable Investment Climate": Abhay Soi
"Unlocking Growth Requires Smoother Approvals and a Favorable Investment Climate": Abhay Soi

Time of India

time01-05-2025

  • Business
  • Time of India

"Unlocking Growth Requires Smoother Approvals and a Favorable Investment Climate": Abhay Soi

New Delhi: Multi-specialty hospital chain Max Healthcare and its Chairman and Managing Director, Abhay Soi , have urged the government to provide stronger policy support to help the private healthcare sector scale up and meet the country's growing medical needs. In a recent interaction with ETHealthworld's Prathiba Raju, Soi outlined both the challenges and opportunities in the current ecosystem, calling for regulatory reforms that can unlock capacity expansion and enable more inclusive healthcare delivery. Soi emphasised the need for enabling regulations, viable insurance pricing, and streamlined approvals to fuel private sector growth. He also highlighted key structural challenges faced by hospitals, especially in metro cities where land and real estate constraints hamper expansion. 'Why should there be a 45-meter height restriction for hospitals when residential and commercial buildings face no such cap?' Soi asked, pointing out how outdated zoning norms restrict vertical growth and unnecessarily inflate project costs. Beyond urban planning hurdles, Soi said the sector is bogged down by excessive red tape. 'We operate under 200 licenses per hospital,' he noted, urging the government to introduce self-certification mechanisms for established hospital chains, similar to those used in other industries. He added that this administrative overload not only delays the commissioning of new hospitals but also increases compliance costs, ultimately impacting affordability for patients. 'India's ambition to become a global healthcare destination and achieve universal health coverage cannot be realized without the active participation of private providers. For that to happen, the government must address regulatory bottlenecks, revisit scheme pricing, and create a more enabling environment for healthcare entrepreneurs,' Soi said. 'We are ready to expand, invest, and serve—but we need the policy ecosystem to partner with us," he added. Soi reaffirmed Max Healthcare's commitment to participate in public health schemes like Ayushman Bharat , but raised concerns about the current pricing model. 'The intent is noble, but we need pricing that reflects the cost of care. Reverse-engineering the model will take time. Unless we build capacity and align costs, it's hard to participate in a meaningful way,' he explained. He reiterated that misaligned pricing discourages larger private players from full-scale participation, potentially limiting the impact of one of India's most ambitious healthcare initiatives. Despite these challenges, Max Healthcare remains on a high-growth trajectory. The hospital chain plans to add over 3,500 beds by FY28 through brownfield expansion, with additional growth expected via acquisitions and Operation & Maintenance (O&M) partnerships. 'We expand only in geographies where we see proven success. We need at least two other major players to be doing well in a region before we enter. Our internal benchmark is a 20–25 per cent return on capital. Yet, unlocking these growth targets requires smoother regulatory approvals and a more favorable investment climate—both of which can be shaped through better government collaboration,' Soi added. The Multi-speciality Hospital-chain is expanding its foothold with a 300-bed super speciality hospital at Dwarka. The hospital chain is also in the broader expansion plan to add 3700 beds across key locations in India by 2028. Apart from Dwarka facility Max Healthcare plans to inaugurate three other hospitals in Mohali, Mumbai and Saket, New Delhi later this year. Addressing the affordability of Max hospitals, Soi said, 'Even as a premium healthcare provider, Max has taken steps to serve a broader cross-section of society. In every 500-bed hospital, around 50 beds are reserved for economically weaker sections (EWS), while 20 per cent are earmarked as multi-sharing wards for middle-income families.' 'Affordability is a function of perception. For one person, a ₹2 lakh bill is reasonable; for another, it's out of reach. Our goal is to accommodate both. But the ability to widen access depends on sustainable operations—and that hinges significantly on regulatory and policy support,' he concluded.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store